Alternatives to Juluca If You Can't Fill Your Prescription

Juluca (dolutegravir/rilpivirine) is a popular two-drug HIV regimen valued for its simplicity and tolerability. But when you can't fill it — whether due to specialty pharmacy routing issues, insurance delays, or other access barriers — the question becomes: what are the alternatives?

The answer depends on your individual history, resistance profile, and why you were on Juluca in the first place. Any switch must be done under the guidance of your HIV provider. Never switch HIV medications on your own. This article provides an overview of options your doctor may consider — not medical advice.

Why Juluca Alternatives Require Medical Oversight

Juluca is only appropriate for adults who are virologically suppressed (HIV-1 RNA below 50 copies/mL) with no prior treatment failure and no resistance to its components. Any alternative must also fit your specific resistance profile, other medications, medical conditions, and preferences. Your HIV provider will review your treatment history before recommending a switch.

Alternative 1: Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide)

Biktarvy is a three-drug, once-daily single pill made by Gilead Sciences. It contains bictegravir (an integrase inhibitor), emtricitabine, and tenofovir alafenamide. Biktarvy is one of the most widely prescribed HIV regimens in the U.S. and is generally available at most retail pharmacies — making it a practical alternative when Juluca access is disrupted.

Biktarvy is approved for both treatment-naive and virologically suppressed adults. It has no food requirement (can be taken with or without food), which some patients prefer over Juluca's strict requirement to take with a meal. The main drawback is that it includes a nucleotide backbone (TAF), which some patients switch away from to reduce long-term renal or bone effects.

Alternative 2: Dovato (Dolutegravir/Lamivudine)

Dovato is the most similar alternative to Juluca. Like Juluca, it is a two-drug regimen — but instead of pairing dolutegravir with rilpivirine, it combines dolutegravir with lamivudine (a nucleoside reverse transcriptase inhibitor, or NRTI). This means Dovato uses a different second agent.

Dovato can be used for treatment-naive adults and for virologically suppressed adults switching from another stable regimen. It is made by ViiV Healthcare (the same company as Juluca), so your provider may be able to keep you within the same drug assistance programs. No food requirement. A generic version of Dovato's components may be available sooner than Juluca's, potentially affecting long-term pricing.

Alternative 3: Cabenuva (Cabotegravir/Rilpivirine — Monthly Injectable)

For patients who want to stop taking a daily oral pill entirely, Cabenuva is a long-acting injectable HIV treatment given once a month at a clinic or doctor's office. It contains cabotegravir (an integrase inhibitor) and rilpivirine (the same NNRTI found in Juluca). Cabenuva is approved for virologically suppressed adults without prior treatment failure or resistance to either component.

The main advantage is eliminating the daily pill burden. The main disadvantage is that it requires clinic visits for injections, which isn't practical for everyone. It is also a specialty medication with its own access and insurance hurdles.

Alternative 4: Triumeq (Abacavir/Dolutegravir/Lamivudine)

Triumeq is a three-drug combination tablet containing dolutegravir (the same integrase inhibitor as Juluca), abacavir, and lamivudine. It is made by ViiV Healthcare and has been available since 2014. Generic versions of Triumeq's components are now available, potentially lowering costs.

Important: Triumeq contains abacavir, which requires a genetic test (HLA-B*5701) before use. Patients who test positive for this allele must not take abacavir due to the risk of a serious hypersensitivity reaction. Your provider will check this before prescribing.

Which Alternative Is Right for You?

There is no universal "best alternative" to Juluca. The right choice depends on:

Your current viral load and CD4 count

Your full resistance history and previous regimens

Kidney function, bone density, and cardiovascular risk factors

Other medications you take (drug interactions)

Insurance coverage and out-of-pocket costs

Your preference for pills vs. injections, food requirements, etc.

The Most Important Step: Talk to Your Provider Before Switching

If you're having trouble getting Juluca filled, contact your HIV provider as your first step — not your last. They can often expedite the fill process, provide samples, or authorize a temporary alternative to keep your viral load suppressed. If a longer-term switch is needed, they'll help determine the best option for your clinical profile.

Before switching regimens, it's worth exhausting all options to find Juluca — see our guide on how to find Juluca in stock near you. If you're still struggling, medfinder can call pharmacies near you to track it down.